Find insight on Germany’s pharmaceutical industry, Novartis and more in the latest Market Talks covering Health Care.

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

The 30% tariff on European goods threatened by US President Donald Trump would, if implemented, be a game-changer for Europe, wiping out whole chunks of transatlantic commerce ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

President Trump threatens to raise tariffs, claiming the European Union won't buy U.S. cars or food — but 2024 trade data shows otherwise.

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

President Donald Trump says he plans to place tariffs of over 10% on smaller countries, including nations in Africa and the ...

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...